Elsevier

Environment International

Volume 117, August 2018, Pages 260-267
Environment International

Impact of declining exposure to secondhand tobacco smoke in public places to decreasing smoking-related cancer mortality in the US population

https://doi.org/10.1016/j.envint.2018.05.008Get rights and content

Highlights

  • We investigated the role of changes secondhand smoke (SHS) declines in public places to smoking-related cancer mortality in the US.

  • We used data from non-smoking adults who participated in NHANES 1988–1994 or 1999–2004.

  • SHS declines were associated with reductions in all-cancer and smoking-related cancer mortality.

  • Smoking bans in public places may have reduced cancer mortality among non-smoking adults.

Abstract

Background

The major decrease in exposure to secondhand smoke (SHS) in public places in recent decades could have contributed to the decline in smoking-related cancer mortality observed in the US population.

Methods

Prospective study among 11,856 non-smoking adults aged ≥40 years who participated in NHANES 1988–1994 or 1999–2004 and were followed for mortality through 2006. We estimated the amount of change in cancer mortality over time attributed to the intermediate pathway of changes in SHS exposure in public places, after adjustment for risk factors and SHS exposure at home.

Results

The adjusted smoking-related cancer mortality rate ratios (95% CI) for a two-fold increase in serum cotinine and a 1-hour increase in occupational SHS exposure time were 1.10 (1.03, 1.17) and 1.14 (1.06, 1.24) for all-cancer, and 1.13 (1.03, 1.24) and 1.14 (1.02, 1.26) for smoking-related cancer, respectively. The absolute reduction in mortality comparing 1999–2004 to 1988–1994 was 75.8 (−25.5, 177.0) and 77.0 (2.6, 151.4) deaths/100,000 person-years, for all-cancer and smoking-related cancer, respectively. Among these avoided all-cancer deaths, 45.8 (2.8, 89.5) and 18.1 (−1.2, 39.6)/100,000 person-year were attributable to changes in serum cotinine concentrations and occupational SHS exposure time, respectively. The corresponding numbers of smoking-related cancer avoided deaths were 36.4 (0.7, 72.8) and 9.9 (−3.8, 24.9)/100,000 person-year.

Conclusions

Declines in SHS exposure were associated with reductions in all-cancer and smoking-related cancer mortality, supporting that smoking bans in public places may have reduced cancer mortality among non-smoking adults.

Introduction

Secondhand tobacco smoke (SHS), the combination of the side-stream smoke emitted from the burning end of a tobacco product and the mainstream smoke exhaled by the smoker, contains >6000 chemicals and is carcinogenic to humans (International Agency for Research on Cancer (IARC), 2012). The 2006 Surgeon General's Report on the Health Consequences of Involuntary Exposure to Tobacco Smoke concluded evidence is sufficient to infer that SHS exposure causes lung cancer (Moritsugu, 2007). Other health effects causally linked to SHS exposure include ischemic heart disease and stroke in adults, and lower respiratory tract infections and impaired lung function in children (Alberg et al., 2014). For many other diseases, there is suggestive evidence for causality (Moritsugu, 2007).

Exposure to SHS can be assessed by interviews or by measuring the levels of cotinine (a nicotine by-product in the body) in biological samples. According to self-reported information and serum cotinine concentrations, exposure to SHS in the United States has declined intensely during the past three decades (Disparities in secondhand smoke exposure–United States, 2008). This phenomenon has been attributed to downward trends in smoking rates and intensity, and to increases in the number of states with smoke-free policies in public places. As of June 30, 2016, a total of 29 US states and the District of Columbia have enacted statewide bans on smoking in all public places and workplaces, including bars, restaurants and private worksites (CDC (Centers for Disease Control and Prevention)).

Cancer death rates in the US, including those that arise at the most common sites (i.e. lung and bronchus, colon and rectum, breast or prostate), have also fallen during the last decades, with an estimated overall decrease of 23% from 1990 to 2012 (Howlader et al., 2016). This decline has been attributed to reductions in tobacco consumption, as well as to better surveillance and treatment options. Little is known, however, about the potential contribution of reductions in SHS exposure to the decline of cancer mortality among nonsmokers. Most studies on the health benefits of smoke-free policies have focused on acute cardiovascular and respiratory effects (Tan & Glantz, 2012; Lin et al., 2013), and on birth outcomes (Peelen et al., 2016). Moreover, a recently published Cochrane review reported evidence of reduced cardiovascular and respiratory mortality after introduction of national smoke-free bans (Frazer et al., 2016). Recently, though, an ecological study within EU countries reported no statistically significant changes in lung cancer mortality trends after the introduction of smoke-free legislation (Lopez-Campos et al., 2017). Although SHS is known to be carcinogenic (International Agency for Research on Cancer (IARC), 2012), the long latency period that is required for most cancers to develop makes it difficult to link changes in SHS exposure to changes in cancer rates.

The objective of this study was to evaluate the hypothesis that population changes in the distribution of SHS exposure in public places explain changes in smoking-related cancer mortality over time in two samples of the non-smoking US population, the U.S. National Health and Nutrition Examination Survey (NHANES) 1988–1994 and 1999–2004. For this purpose, we used individual information on serum cotinine and made adjustments for SHS exposure at home, so that our analyses reflect SHS exposure not coming from private settings. Moreover, to differentiate between occupational SHS exposure and SHS exposure from other public places, we also evaluated self-reported occupational SHS exposure time (hours/day). To address the study objectives, we implemented a causal inference mediation approach (Lange & Hansen, 2011) using study period as a major determinant of cancer mortality and changes in SHS exposure as a potential mediator of the relation between period and cancer mortality (see Supplemental Fig. S1). This method allows us to estimate the proportion of the decline in smoking-related cancer mortality rates among nonsmokers recruited in 1988–1994 and 1999–2004 that can be independently attributed to changes in SHS exposure.

Section snippets

Study population

NHANES is a program of studies designed to assess the health and nutritional status of the general population in the United States. The survey uses a complex multistage sampling design to obtain representative samples of the non-institutionalized US population (Centers for Disease Control and Prevention (CDC)), and it is unique in that it combines interviews and physical examinations. Blood and urine specimens are obtained from NHANES participants who give consent for their specimens to be used

Results

The age, sex and race-adjusted smoking-related cancer mortality rates were 249.1 and 158.4 deaths per 100,000 person-year in 1988–1994 and 1999–2004, respectively (Table 1). The corresponding all-cause cancer mortality rates were 401.3 and 315.3 deaths per 100,000 person-years (data not shown). Smoking-related cancer mortality rates decreased in all subgroups evaluated except in obese participants and in participants exposed to SHS at home.

Fig. 1 shows the progressive reduction in

Discussion

Smoking-related cancer mortality rates among non-smoking US adults decreased about 36% from 1988 to 1994 to 1999–2004. After accounting for potential confounders and SHS exposure at home, around 46% of the decrease in cancer mortality could be attributed to declines in SHS exposure in public places based on statistically significant serum cotinine estimates. Our results are unique in that they present the first evidence of the important contribution that smoking bans may have had in the cancer

Author contributions

MTP, ANA and EGE conceived the study. MTP and AJ performed the statistical analyses. EGE drafted the initial document. All authors reviewed the manuscript for important intellectual content. All authors had full access to all of the data (including statistical reports and tables) in the study and can take responsibility for the integrity of the data and the accuracy of the data analysis. MTP is the guarantor of this study.

Funding

This work was supported by the Strategic Action for Research in Health Sciences (CP12/03080; PI15/00071); CIBERESP and CIBEROBN. The Strategic Action for Research in Health Sciences, CIBEROBN and CIBERESP are initiatives from the Carlos the third National Health Institutes in Madrid and the Spanish Ministry of Economy and Competitiveness and are co-funded with European Funds for Regional Development (FEDER).

Competing interests

None to declare.

Consent and approval

NHANES study protocols were approved by the institutional review board of the National Center for Health Statistics, and written informed consent was obtained from all participants.

Data sharing

Anonymized, non-identifiable participant level cross sectional survey data are publicly available at https://wwwn.cdc.gov/nchs/nhanes/. The statistical code and reduced dataset restricted to the study population and variables used for this analysis is available upon request to the corresponding author.

References (35)

  • M. Eriksen et al.

    The tobacco altas. Atlanta,Georgia USA

    Am. Cancer Soc.

    (2015)
  • K. Frazer et al.

    Legislative smoking bans for reducing harms from secondhand smoke exposure, smoking prevalence and tobacco consumption

    Cochrane Database Syst. Rev.

    (2016)
  • R. Hornung et al.

    Estimation of average concentration in the presence of nondetectable values

    Appl. Occup. Environ. Hyg.

    (1990)
  • N. Howlader et al.

    SEER Cancer Statistics Review 1975–2013

    (April 2016)
  • Institute of Medicine (US) Committee on Secondhand Smoke Exposure and Acute Coronary Events

    Secondhand smoke exposure and cardiovascular effects

  • International Agency for Research on Cancer (IARC)

    Evaluating the Effectiveness of Smoke-free Policies

  • International Agency for Research on Cancer (IARC)

    Monographs on the evaluation of carcinogenic risks to humans

  • Cited by (11)

    • Associations of urinary perchlorate, nitrate and thiocyanate with central sensitivity to thyroid hormones: A US population-based cross-sectional study

      2022, Environment International
      Citation Excerpt :

      A previous cross-sectional study in US women with urinary iodine levels < 100 μg/L found that the regression coefficient between perchlorate and T4 was greater in women with high cotinine measurements (Steinmaus et al., 2007). Cotinine, the metabolite of nicotine, has a half-life of 15–20 h in plasma (García-Esquinas et al., 2018), and had been applied as a biomarker f or recent smoking (Benowitz et al., 2009). Compared with respondents’ replies to questionnaires, misclassification introduced by biased reporting or recall could be avoided with the sensitive biomarker.

    • Burden of disease attributable to second-hand smoke exposure: A systematic review

      2019, Preventive Medicine
      Citation Excerpt :

      When PAFs were not reported, if possible, we estimated them using the RR and the prevalence estimates reported in the paper. Only RR defined for dichotomous exposure, i.e. SHS exposed/not exposed, were used in the PAF computation, thus the PAF was not estimated when this was not available (García-Esquinas et al., 2018). For each disease the PAF were highly heterogeneous among studies.

    View all citing articles on Scopus
    View full text